1. Home
  2. VTAK vs KWE Comparison

VTAK vs KWE Comparison

Compare VTAK & KWE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VTAK
  • KWE
  • Stock Information
  • Founded
  • VTAK 2002
  • KWE 2017
  • Country
  • VTAK United States
  • KWE Canada
  • Employees
  • VTAK N/A
  • KWE N/A
  • Industry
  • VTAK Medical/Dental Instruments
  • KWE
  • Sector
  • VTAK Health Care
  • KWE
  • Exchange
  • VTAK Nasdaq
  • KWE Nasdaq
  • Market Cap
  • VTAK 1.4M
  • KWE 1.2M
  • IPO Year
  • VTAK 2018
  • KWE N/A
  • Fundamental
  • Price
  • VTAK $0.33
  • KWE $0.60
  • Analyst Decision
  • VTAK
  • KWE
  • Analyst Count
  • VTAK 0
  • KWE 0
  • Target Price
  • VTAK N/A
  • KWE N/A
  • AVG Volume (30 Days)
  • VTAK 152.4K
  • KWE 5.2M
  • Earning Date
  • VTAK 11-13-2024
  • KWE 01-16-2025
  • Dividend Yield
  • VTAK N/A
  • KWE N/A
  • EPS Growth
  • VTAK N/A
  • KWE N/A
  • EPS
  • VTAK N/A
  • KWE N/A
  • Revenue
  • VTAK $399,000.00
  • KWE $1,132,395.00
  • Revenue This Year
  • VTAK $637.10
  • KWE $817.82
  • Revenue Next Year
  • VTAK $177.13
  • KWE N/A
  • P/E Ratio
  • VTAK N/A
  • KWE N/A
  • Revenue Growth
  • VTAK 27.07
  • KWE 75.25
  • 52 Week Low
  • VTAK $0.31
  • KWE $0.53
  • 52 Week High
  • VTAK $4.10
  • KWE $16.73
  • Technical
  • Relative Strength Index (RSI)
  • VTAK 34.81
  • KWE 41.54
  • Support Level
  • VTAK $0.31
  • KWE $0.53
  • Resistance Level
  • VTAK $0.37
  • KWE $1.50
  • Average True Range (ATR)
  • VTAK 0.04
  • KWE 0.13
  • MACD
  • VTAK 0.00
  • KWE 0.01
  • Stochastic Oscillator
  • VTAK 20.00
  • KWE 7.44

About VTAK Catheter Precision Inc.

Catheter Precision Inc is engaged in design, manufacture and sale of new and innovative medical technologies primarily focused in the field of cardiac electrophysiology, or EP. The Company's primary product is the View into Ventricular Onset System (VIVO or VIVO System) which is a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. The VIVO system has achieved a CE Mark allowing it to be commercialized in the European Union and has been placed at several hospitals in Europe. Its newest product, the Surgical Vessel Closing Pressure Device (LockeT), is a suture retention device indicated for wound healing by distributing suture tension.

About KWE KWESST Micro Systems Inc.

KWESST Micro Systems Inc develops and commercializes next-generation tactical systems. The company offers breakthrough technology in lethal and non-lethal systems with broad application, including law enforcement and personal defence, modernized digitization of tactical forces for shared situational awareness and targeting, and counter-measures against threats such as drones, lasers and electronic detection.

Share on Social Networks: